Twinning Call 2026
Health
 
Organiser
EP PerMed

Budget

This call offers up to 50,000 EUR to activities that facilitate the exchange of solutions or approaches in personalised medicine and build up the capacities and capabilities of one or both participating parties.

Key dates and deadline

13 October 2025 – 26 February 2026 - Online matchmaking period 10 December 2025 - Opening of the Call for Proposals submission 17 December 2025 at 12:00 CET - Call information webinar 15 January 2026 - Online matchmaking event 26 February 2026 at 16:00 CET - Deadline for proposals submissions 27 February – 20 March 2026 - Eligibility check 23 March 2026 - Notification of eligibility check outcome and invite to online pitching sessions 14 – 21 April 2026 - Online pitching sessions 06 May 2026 - Final Results notification 06 May – 08 June - Stand still period Week beginning 08 June 2026 - Kick off meeting, onboarding and contracting begins

Details

Those interested to apply to the EP PerMed Twinning Call, are encouraged to identify potential partners through the online matchmaking event. On 15 January 2026 (12:00–14:00 CET), interested donor and receiver organisations will pitch their PM solutions or needs to support the formation of twinning partnerships between health and care providers across Horizon Europe countries. The Twinning Call supports partnerships where one organisation shares a proven, transferable PM solution or approach with one or two others looking to adapt or implement it in practice. Eligible activities focus on real-world implementation across the health value chain (from diagnosis to patient management) and must have a clear impact on patient care. Early-stage research, policy actions, awareness campaigns, or technologies below TRL 9 are out of scope.

Eligibility

Applicants must be legal entities registered in an EU Member State or a country associated with Horizon Europe (individuals are not eligible). Organisations that are partners within the EP PerMed consortium are not eligible. The proposed solution must fit the definition of Personalised Medicine (PM) as set out in the call. The PM solution must be ready for implementation; technological solutions must be at TRL 9 and CE-marked, where applicable. Consortium requirements Applications must be submitted by a completed consortium consisting of 1 Twinning Donor and 1–2 Twinning Receivers. The consortium must be transnational, involving 2–3 organisations from at least two different eligible countries. Consortium members must be legally and financially independent. Eligible organisations: Twinning Donors (health and care providers with an existing PM solution available for transfer) and Twinning Receivers (health and care providers seeking to adopt a PM solution).

Additional information

Eligible costs and project duration The types of activities that may be awarded funding include hosting meetings or working groups, travel expenses, or fees for professional services. Costs for the further development of PM solutions are not eligible. Costs for devices, instruments and equipment are not eligible. Funding will support the Twinning activity up to the submission of the final activity report, which must be delivered no later than 6 May 2027.

How to apply?

https://www.eppermed.eu/funding-projects/calls/twinning-call-2026/